GaviLAX - 43386-312-14 - (Polyethylene Glycol-3350)

Alphabetical Index


Drug Information of GaviLAX

Product NDC: 43386-312
Proprietary Name: GaviLAX
Non Proprietary Name: Polyethylene Glycol-3350
Active Ingredient(s): 17    g/1 & nbsp;   Polyethylene Glycol-3350
Administration Route(s): ORAL
Dosage Form(s): POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of GaviLAX

Product NDC: 43386-312
Labeler Name: GAVIS Pharmaceuticals, LLC
Product Type: HUMAN OTC DRUG
FDA Application Number: ANDA091077
Marketing Category: ANDA
Start Marketing Date: 20091009

Package Information of GaviLAX

Package NDC: 43386-312-14
Package Description: 30 POWDER, FOR SOLUTION in 1 BOTTLE (43386-312-14)

NDC Information of GaviLAX

NDC Code 43386-312-14
Proprietary Name GaviLAX
Package Description 30 POWDER, FOR SOLUTION in 1 BOTTLE (43386-312-14)
Product NDC 43386-312
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Polyethylene Glycol-3350
Dosage Form Name POWDER, FOR SOLUTION
Route Name ORAL
Start Marketing Date 20091009
Marketing Category Name ANDA
Labeler Name GAVIS Pharmaceuticals, LLC
Substance Name POLYETHYLENE GLYCOL 3350
Strength Number 17
Strength Unit g/1
Pharmaceutical Classes

Complete Information of GaviLAX


General Information